Literature DB >> 1360873

Expression and functional activity of P-glycoprotein in cultured cerebral capillary endothelial cells.

E J Hegmann1, H C Bauer, R S Kerbel.   

Abstract

Analysis of a panel of endothelial cells passaged between 5 and 25 times and derived from various organs and species demonstrated that murine and porcine cerebral capillary endothelial cells actively excluded the fluorescent dye rhodamine 123, a substrate of P-glycoprotein. In addition, rhodamine 123 accumulation could be enhanced by the multidrug resistance chemosensitizer verapamil, known to reduce P-glycoprotein-mediated drug efflux. Cloned murine and porcine cerebral capillary endothelial cells were immunoreactive with the C219 monoclonal antibody to P-glycoprotein, and a C219 epitope-specific blocking peptide could abolish staining. The antiproliferative and cytotoxic effects of vincristine, but not cis-platinum(II) diamminedichloride, were increased by the addition of either verapamil or cyclosporin A to brain endothelial cell cultures in a 72-h assay, as determined by [3H]thymidine incorporation and total protein measurement. Cyclosporin A was a more effective reversal agent than verapamil. Thus, a P-glycoprotein isoform may be constitutively expressed in brain endothelial cells in vitro and supports the available data on in situ immunohistochemical staining of P-glycoprotein at the blood-brain barrier. In addition, these findings may indicate that one function of P-glycoprotein in vivo at the blood-brain barrier is the exclusion of xenobiotics from central nervous system tissues.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1360873

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

Review 1.  The impact of efflux transporters in the brain on the development of drugs for CNS disorders.

Authors:  Eve M Taylor
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders.

Authors:  Gloria Lee; Reina Bendayan
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

Review 3.  Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain.

Authors:  Sagar Agarwal; Ramola Sane; Rajneet Oberoi; John R Ohlfest; William F Elmquist
Journal:  Expert Rev Mol Med       Date:  2011-05-13       Impact factor: 5.600

4.  Evaluation of the role of P-glycoprotein in ivermectin uptake by primary cultures of bovine brain microvessel endothelial cells.

Authors:  J M Rose; S L Peckham; J L Scism; K L Audus
Journal:  Neurochem Res       Date:  1998-02       Impact factor: 3.996

5.  The volume-activated chloride current in human endothelial cells depends on intracellular ATP.

Authors:  M Oike; G Droogmans; B Nilius
Journal:  Pflugers Arch       Date:  1994-05       Impact factor: 3.657

6.  MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors.

Authors:  K Tóth; M M Vaughan; N S Peress; H K Slocum; Y M Rustum
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

7.  Drug resistance-associated factors in primary and secondary glioblastomas and their precursor tumors.

Authors:  D S Tews; A Nissen; C Külgen; A K Gaumann
Journal:  J Neurooncol       Date:  2000-12       Impact factor: 4.130

8.  BBB transport and P-glycoprotein functionality using MDR1A (-/-) and wild-type mice. Total brain versus microdialysis concentration profiles of rhodamine-123.

Authors:  E C de Lange; G de Bock; A H Schinkel; A G de Boer; D D Breimer
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

9.  Expression of drug resistance related proteins in sarcomas of the pulmonary artery and poorly differentiated leiomyosarcomas of other origin.

Authors:  A Gaumann; D S Tews; T Mentzel; P K Petrow; E Mayer; M Otto; C J Kirkpatrick; J Kriegsmann
Journal:  Virchows Arch       Date:  2003-05-13       Impact factor: 4.064

Review 10.  Multidrug resistance in human cancer.

Authors:  M Lehnert
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.